Literature DB >> 33849550

Role of LncRNAs in regulating cancer amino acid metabolism.

Yuhong Guo1,2,3,4, Bin Lv1,2,3,4, Renfeng Liu1,2,3,4, Zhengzai Dai1,2,3,4, Feifei Zhang1, Yiping Liang1, Bo Yu1,2,3,4, Duo Zeng1,2,3,4, Xiao-Bin Lv5, Zhiping Zhang6,7,8.   

Abstract

The metabolic change of tumor cells is an extremely complicated process that involves the intersection and integration of various signal pathways. Compared with normal tissues, cancer cells show distinguished metabolic characteristics called metabolic reprogramming, which has been considered as a sign of cancer occurrence. With the deepening of tumor research in recent years, people gradually found that amino acid metabolism played crucial roles in cancer progression. Long non-coding RNAs (lncRNAs), which are implicated in many important biological processes, were firstly discovered dysregulating in cancer tissues and participating in extensive regulation of tumorigenesis. This review focuses on the reprogramming of amino acid metabolism in cancers and how lncRNAs participate in the regulatory network by interacting with other macromolecular substances. Understanding the functions of lncRNA in amino acid reprogramming in tumors might provide a new vision on the mechanisms of tumorigenesis and the development of new approaches for cancer therapy.

Entities:  

Keywords:  Amino acid; Cancer; Glutamine; Metabolism; lncRNA

Year:  2021        PMID: 33849550     DOI: 10.1186/s12935-021-01926-8

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  97 in total

Review 1.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

Authors:  Sophia Y Lunt; Matthew G Vander Heiden
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

Review 2.  Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis.

Authors:  Camille Lehuédé; Fanny Dupuy; Rebecca Rabinovitch; Russell G Jones; Peter M Siegel
Journal:  Cancer Res       Date:  2016-09-01       Impact factor: 12.701

Review 3.  Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.

Authors:  Dania Daye; Kathryn E Wellen
Journal:  Semin Cell Dev Biol       Date:  2012-02-11       Impact factor: 7.727

Review 4.  Targeting the PI3K pathway in cancer: are we making headway?

Authors:  Filip Janku; Timothy A Yap; Funda Meric-Bernstam
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

Review 5.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 6.  AMPK signalling in health and disease.

Authors:  David Carling
Journal:  Curr Opin Cell Biol       Date:  2017-02-21       Impact factor: 8.382

Review 7.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.

Authors:  Zhaoyong Li; Huafeng Zhang
Journal:  Cell Mol Life Sci       Date:  2015-10-23       Impact factor: 9.261

Review 8.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

Review 9.  Metabolic regulation of cell growth and proliferation.

Authors:  Jiajun Zhu; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

Review 10.  The Warburg effect: 80 years on.

Authors:  Michelle Potter; Emma Newport; Karl J Morten
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

View more
  7 in total

1.  Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity.

Authors:  Mithlesh Kumar Temre; Saveg Yadav; Yugal Goel; Shrish Kumar Pandey; Ajay Kumar; Sukh Mahendra Singh
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 2.  Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy.

Authors:  Yi-Zhen Wu; Yong-Han Su; Ching-Ying Kuo
Journal:  Biomedicines       Date:  2022-05-23

3.  Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer.

Authors:  Yin-Wei Dai; Zhi-Kai Wen; Zhi-Xuan Wu; Hao-Dong Wu; Lin-Xi Lv; Cong-Zhi Yan; Cong-Hui Liu; Zi-Qiong Wang; Chen Zheng
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

Review 4.  New Insights into LINC00346 and its Role in Disease.

Authors:  Juan Lu; Zhaoying Xiao; Mengqiu Xu; Lanjuan Li
Journal:  Front Cell Dev Biol       Date:  2022-01-13

5.  Prognostic Implication of Metabolic Syndrome in Patients with Nasopharyngeal Carcinoma: A Large Institution-Based Cohort Study from an Endemic Area.

Authors:  Shengyan Huang; Xirong Tan; Ping Feng; Sha Gong; Qingmei He; Xunhua Zhu; Na Liu; Yingqing Li
Journal:  Cancer Manag Res       Date:  2021-12-24       Impact factor: 3.989

6.  LncRNA-ENST00000543604 exerts a tumor-promoting effect via miRNA 564/AEG-1 or ZNF326/EMT and predicts the prognosis of and chemotherapeutic effect in colorectal cancer.

Authors:  Weimin Wang; Zhen Zhou; Xiaojun Dai; Haibo Wang; Jun Jin; Ke Min; Yunfan Wang; Mengying Lv; Yanqing Liu; Yan Zhou
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

Review 7.  Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.

Authors:  Fereydoon Abedi-Gaballu; Elham Kamal Kazemi; Seyed Ahmad Salehzadeh; Behnaz Mansoori; Farhad Eslami; Ali Emami; Gholamreza Dehghan; Behzad Baradaran; Behzad Mansoori; William C Cho
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.